华恒生物：聘任曾苗担任公司证券事务代表

每日经济新闻2025-04-22

每经AI快讯，华恒生物（SH 688639，收盘价：27.8元）4月22日晚间发布公告称，安徽华恒生物科技股份有限公司董事会于近日收到樊义先生关于职务调整的报告，因内部工作调整原因，樊义先生不再担任公司董事会秘书职务，仍继续担任公司董事、副总经理及财务负责人职务。为确保公司董事会的日常运作及公司信息披露等工作的有序开展，公司第四届董事会第十九次会议审议通过《关于聘任公司证券事务代表的议案》，同意...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529658846?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-22 21:03","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529658846","market":"sh","top_or_hot":-1,"title":"华恒生物：聘任曾苗担任公司证券事务代表","media":"每日经济新闻","content":"<div>\n<p>每经AI快讯，华恒生物（SH 688639，收盘价：27.8元）4月22日晚间发布公告称，安徽华恒生物科技股份有限公司董事会于近日收到樊义先生关于职务调整的报告，因内部工作调整原因，樊义先生不再担任公司董事会秘书职务，仍继续担任公司董事、副总经理及财务负责人职务。为确保公司董事会的日常运作及公司信息披露等工作的有序开展，公司第四届董事会第十九次会议审议通过《关于聘任公司证券事务代表的议案》，同意...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221041294de29e2&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华恒生物：聘任曾苗担任公司证券事务代表</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华恒生物：聘任曾苗担任公司证券事务代表\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-22 21:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221041294de29e2&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>每经AI快讯，华恒生物（SH 688639，收盘价：27.8元）4月22日晚间发布公告称，安徽华恒生物科技股份有限公司董事会于近日收到樊义先生关于职务调整的报告，因内部工作调整原因，樊义先生不再担任公司董事会秘书职务，仍继续担任公司董事、副总经理及财务负责人职务。为确保公司董事会的日常运作及公司信息披露等工作的有序开展，公司第四届董事会第十九次会议审议通过《关于聘任公司证券事务代表的议案》，同意...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221041294de29e2&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688639","symbol_name":"华恒生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221041294de29e2&s=b","article_id":"2529658846","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221041294de29e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529658846","pubTimestamp":1745327033,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"每经AI快讯，华恒生物 4月22日晚间发布公告称，安徽华恒生物科技股份有限公司董事会于近日收到樊义先生关于职务调整的报告，因内部工作调整原因，樊义先生不再担任公司董事会秘书职务，仍继续担任公司董事、副总经理及财务负责人职务。截至发稿，华恒生物市值为69亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161027":"证券","688639":"华恒生物","BK0229":"化学制品"},"translate_title":"Huaheng Biotech: Appointed Zeng Miao as the company's securities affairs representative","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"688639":1},"content_text":"每经AI快讯，华恒生物（SH 688639，收盘价：27.8元）4月22日晚间发布公告称，安徽华恒生物科技股份有限公司董事会于近日收到樊义先生关于职务调整的报告，因内部工作调整原因，樊义先生不再担任公司董事会秘书职务，仍继续担任公司董事、副总经理及财务负责人职务。为确保公司董事会的日常运作及公司信息披露等工作的有序开展，公司第四届董事会第十九次会议审议通过《关于聘任公司证券事务代表的议案》，同意聘任曾苗先生担任公司证券事务代表，协助董事会秘书开展相关工作。截至发稿，华恒生物市值为69亿元。每经头条（nbdtoutiao）——特朗普威逼鲍威尔：“下台还不够快”！美元指数第六次跌破100大关，分析师：这是美元空头的盛宴(记者 曾健辉)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529658846","isCrawlerRequest":true}